We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+7.53%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$162M
Cap. Flow
+$141M
Cap. Flow %
13.21%
Top 10 Hldgs %
37.33%
Holding
532
New
105
Increased
323
Reduced
47
Closed
36

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$9.31M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.32M
3
NVDA icon
NVIDIA
NVDA
+$6.63M
4
MSFT icon
Microsoft
MSFT
+$6.29M
5
UGL icon
ProShares Ultra Gold
UGL
+$5.95M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$5.72M
2
PDD icon
Pinduoduo
PDD
+$4.15M
3
PG icon
Procter & Gamble
PG
+$2.96M
4
SNPS icon
Synopsys
SNPS
+$2.64M
5
AMAT icon
Applied Materials
AMAT
+$2.41M

Sector Composition

Rank Sector Weight
1 Technology 38.03%
2 Healthcare 25.43%
3 Consumer Discretionary 12.38%
4 Communication Services 10.24%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MXCT icon
401
MaxCyte
MXCT
$136M
$93K 0.01%
22,366
+2,154
+11% +$8.14K
IWY icon
402
iShares Russell Top 200 Growth ETF
IWY
$16.6B
$92K 0.01%
+391
New +$89.8K
ESPR
403
DELISTED
Esperion Therapeutics
ESPR
$91.9K 0.01%
+41,779
New +$97.5K
SIGA icon
404
SIGA Technologies
SIGA
$206M
$91K 0.01%
15,140
+1,413
+10% +$9.45K
OABI icon
405
OmniAb
OABI
$497M
$90.8K 0.01%
25,659
+2,932
+13% +$11.6K
PAHC icon
406
Phibro Animal Health
PAHC
$1.37B
$90.6K 0.01%
4,312
+400
+10% +$9.26K
GLUE icon
407
Monte Rosa Therapeutics
GLUE
$1.36B
$90.4K 0.01%
+13,027
New +$97.8K
KALV
408
DELISTED
KalVista Pharmaceuticals
KALV
$87.5K 0.01%
10,329
+2,043
+25% +$21.2K
AURA icon
409
Aura Biosciences
AURA
$802M
$87.1K 0.01%
+10,592
New +$99.7K
PSNL icon
410
Personalis
PSNL
$1.52B
$86.6K 0.01%
+14,980
New +$69.1K
ANAB icon
411
AnaptysBio
ANAB
$1.69B
$85.4K 0.01%
6,452
+644
+11% +$15.6K
SIVR icon
412
abrdn Physical Silver Shares ETF
SIVR
$4.53B
$82.7K 0.01%
3,000
-71,900
-96% -$2.15M
CDXS icon
413
Codexis
CDXS
$172M
$82.3K 0.01%
+17,255
New +$71K
LKFT
414
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
$81.5K 0.01%
2,962
-937
-24% -$26.1K
PRME icon
415
Prime Medicine
PRME
$580M
$81.2K 0.01%
27,811
+4,725
+20% +$16.6K
RGNX icon
416
Regenxbio
RGNX
$720M
$81.2K 0.01%
10,505
+999
+11% +$9.38K
ALMS
417
Alumis Inc
ALMS
$3.26B
$78.7K 0.01%
+10,013
New +$100K
SANA icon
418
Sana Biotechnology
SANA
$1.13B
$77.2K 0.01%
47,341
+4,554
+11% +$13.6K
TSHA icon
419
Taysha Gene Therapies
TSHA
$2.05B
$75.2K 0.01%
43,456
+4,039
+10% +$8.38K
YMAB
420
DELISTED
Y-mAbs Therapeutics
YMAB
$74.4K 0.01%
9,497
+925
+11% +$11.3K
DSGN icon
421
Design Therapeutics
DSGN
$917M
$74.1K 0.01%
+12,006
New +$69.5K
CRVS icon
422
Corvus Pharmaceuticals
CRVS
$1.27B
$72.9K 0.01%
+13,625
New +$102K
NGNE icon
423
Neurogene
NGNE
$738M
$72K 0.01%
+3,150
New +$117K
OLMA icon
424
Olema Pharmaceuticals
OLMA
$913M
$70.8K 0.01%
12,149
+1,135
+10% +$11.3K
SAGE
425
DELISTED
Sage Therapeutics
SAGE
$70.4K 0.01%
12,971
+1,229
+10% +$7.51K
15 16
17
18 19

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q4 2024 Portfolio in Review

As of Q4 2024, China Universal Asset Management Company held 532 positions worth $1.07B, up 18% from $907M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

China Universal Asset Management Company deployed $141M of net new capital in Q4 2024, opening 105 new positions and adding to 323 existing holdings. Its largest new stake was Astera Labs: 26,000 shares worth $3.44M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Pinduoduo, an estimated $4.15M trimmed.

  • China Universal Asset Management Company's largest Q4 2024 buy was Astera Labs: 26,000 shares worth $3.44M.
  • China Universal Asset Management Company added most to Apple in Q4 2024, an estimated $9.31M increase.
  • China Universal Asset Management Company's biggest Q4 2024 reduction was Pinduoduo, cutting an estimated $4.15M.
  • China Universal Asset Management Company fully exited Alibaba in Q4 2024, selling an estimated $5.72M.
  • China Universal Asset Management Company's ten largest holdings make up 37% of its $1.07B portfolio in Q4 2024.
  • China Universal Asset Management Company opened 105 new positions and closed 36 in Q4 2024.
  • China Universal Asset Management Company's portfolio value rose 18% quarter-over-quarter to $1.07B.

Based on China Universal Asset Management Company's 13F filing for Q4 2024, filed 24 Jan 2025.